Latest Healthcare Policy news from across the web.
Kalshi, one of the world’s largest prediction market exchanges, plans to take bets on clinical trials and regulatory approvals
Read full article →Kalshi allows bets on clinical trial outcomes, Eli Lilly buys a psychedelic medicine, and more biotech news from The Readout
Read full article →Prediction markets have permeated the worlds of sports, politics, and reality television shows. Now, the biopharma industry could be next.
Read full article →Eli Lilly is buying the psychedelics-focused biotech AtaiBeckley for $2.8 billion upfront, a move that will expand its neuroscience pipeline.
Read full article →Trump's pandemic preparedness nominee testifies, the "fang-to-pharmacy" pipeline, and more health news from Morning Rounds
Read full article →Amylyx Pharmaceuticals will soon read out results from a study evaluating a new treatment for a rare endocrine disorder, a pivotal moment for patients and the company.
Read full article →CMS wants to build a standardized payment structure for clinical software and AI that factors in their impact on patient outcomes.
Read full article →“No one built a psychiatric unit to solve hunger,” writes clinical dietician Cole Hanson. But patients come anyway.
Read full article →“Some of the most powerful medicines we will ever find are already here, carried in the fangs, stingers, and saliva of creatures we’ve been taught to fear,” writes Steve Midway.
Read full article →When the body’s most important blood vessel tears from the inside, it’s a medical emergency that can be years in the making.
Read full article →President Trump said TrumpRx is the biggest thing to happen in healthcare in decades. But an NPR analysis finds drugmakers are only offering deals on a few of their medicines.
Read full article →Dr. Erica Schwartz answered questions from a Senate committee Wednesday, as she sought confirmation to become the next director of the Centers for Disease Control and Prevention.
Read full article →